Sharda Cropchem

Why is Sharda Cropchem Ltd falling/rising?

As of 07-Aug, Sharda Cropchem Ltd's stock price is declining, currently at 814.55, down 1.02%. The stock has underperformed against the Sensex and has seen a significant drop of 10.98% over the past month, with reduced investor interest and negative financial results contributing to the ongoing weakness.

As of 07-Aug, Sharda Cropchem Ltd's stock price is falling, currently at 814.55, reflecting a decrease of 8.4 points or 1.02%. The stock has been underperforming compared to the benchmark Sensex, which has gained 0.52% over the past week, while Sharda Cropchem has declined by 0.62%. Over the past month, the stock has experienced a significant drop of 10.98%, contrasting with the Sensex's modest gain of 0.41%.<BR><BR>The stock has been on a downward trend, having fallen consecutively for the last three days, resulting in a total decline of 3.13% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent weakness in its price performance. Investor participation has also decreased, with delivery volume dropping by 28.33% compared to the 5-day average, suggesting reduced interest from traders.<BR><BR>Financial results have contributed to this decline, as the company reported flat results for the quarter ending June 26, with both profit before tax and profit after tax falling by approximately 38.6% and 38.3%, respectively. Furthermore, institutional investors have reduced their stakes by 2% over the previous quarter, which may indicate a lack of confidence in the stock's future performance. Despite the company being net-debt free and having shown healthy long-term growth in net sales and operating profit, the significant underperformance against the broader market, with a 1-year return of -18.00% compared to the BSE500's 4.11% gain, has led to a negative sentiment surrounding the stock.

Which are the latest news on Sharda Cropchem?

Are Sharda Cropchem Ltd latest results good or bad?

Sharda Cropchem Ltd's latest Q1 FY27 results show mixed performance, with a 9.03% revenue growth overshadowed by a 38.34% decline in net profit and a significant drop in operating and PAT margins, indicating potential challenges in profitability and cost management. Investors should be cautious due to these concerning trends.

Sharda Cropchem Ltd's latest results for Q1 FY27 indicate a mixed performance, leaning towards the negative side. While the company reported a revenue growth of 9.03% year-on-year, this was overshadowed by a significant decline in net profit, which fell by 38.34% compared to the same quarter last year. <BR><BR>The operating margin also saw a notable contraction, decreasing to 17.32% from 21.86% a year ago, reflecting challenges in maintaining profitability amidst rising costs or pricing pressures. Additionally, the profit after tax (PAT) margin dropped sharply to 8.20%, down from 14.50% in the previous year.<BR><BR>Overall, the results highlight a concerning trend of margin compression despite revenue growth, raising questions about the company's pricing power and cost management in a challenging market environment. Investors may need to be cautious as these results suggest potential structural issues that could impact future profitability.

Should I buy, sell or hold Sharda Cropchem Ltd?

When is the next results date for Sharda Cropchem Ltd?

The next results date for Sharda Cropchem Ltd is July 29, 2026.

The next results date for Sharda Cropchem Ltd is scheduled for July 29, 2026.

How big is Sharda Cropchem?

As of 10th June, Sharda Cropchem Ltd has a market capitalization of 8,264.00 Cr, with recent net sales of 5,267.58 Cr and a net profit of 680.85 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Sharda Cropchem Ltd has a market capitalization of 8,264.00 Cr, classifying it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 5,267.58 Cr, while the sum of Net Profit for the same period is 680.85 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds stand at 2,500.57 Cr, and Total Assets are valued at 4,713.29 Cr.

Who are in the management team of Sharda Cropchem?

The management team of Sharda Cropchem includes Ramprakash V Bubna (Chairman & Managing Director), Sharda R Bubna, Ashish R Bubna, and Manish R Bubna (Whole-time Directors), along with several Independent Directors: M S Sundara Rajan, Shitin Desai, Shobhan Thakore, and Sonal Desai, plus Jetkin N Gudhka as Company Secretary & Compliance Officer. This team is responsible for the company's strategic direction and governance.

The management team of Sharda Cropchem includes the following individuals:<BR><BR>1. **Ramprakash V Bubna** - Chairman & Managing Director<BR>2. **Sharda R Bubna** - Whole-time Director<BR>3. **Ashish R Bubna** - Whole-time Director<BR>4. **Manish R Bubna** - Whole-time Director<BR>5. **M S Sundara Rajan** - Independent Director<BR>6. **Shitin Desai** - Independent Director<BR>7. **Shobhan Thakore** - Independent Director<BR>8. **Jetkin N Gudhka** - Company Secretary & Compliance Officer<BR>9. **Sonal Desai** - Independent Director<BR><BR>This team plays a crucial role in the strategic direction and governance of the company.

Who are the peers of the Sharda Cropchem?

Sharda Cropchem's peers include UPL, P I Industries, Sumitomo Chemical, Bayer CropScience, Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chemicals, and Bharat Rasayan. Sharda Cropchem shows excellent growth and management risk, with a 1-year return of 8.30%, outperforming Bayer CropSci. but underperforming NACL Industries.

Peers: The peers of Sharda Cropchem are UPL, P I Industries, Sumitomo Chemi., Bayer CropSci., Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., and Bharat Rasayan.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci. and Dhanuka Agritech, while Good management risk is found at UPL, P I Industries, Sumitomo Chemi., Sharda Cropchem, and the rest. Average management risk is present at Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, and the rest. For Growth, Excellent growth is noted at Sharda Cropchem, while Below Average growth is seen at UPL, P I Industries, Sumitomo Chemi., Bayer CropSci., Dhanuka Agritech, Rallis India, NACL Industries, Bhagiradha Chem., Bharat Rasayan, and the rest. In terms of Capital Structure, Excellent capital structure is found at P I Industries, Sumitomo Chemi., Bayer CropSci., Sharda Cropchem, Dhanuka Agritech, Rallis India, Bharat Rasayan, and the rest, while Below Average capital structure is observed at NACL Industries and the rest.<BR><BR>Return Snapshot: Sharda Cropchem has a 1-year return of 8.30%, which is higher than Bayer CropSci. at -22.15%, the peer with the lowest return, and lower than NACL Industries at 12.92%, the peer with the highest return. Additionally, several peers, including Dhanuka Agritech, Rallis India, and Bharat Rasayan, have negative six-month returns.

What does Sharda Cropchem do?

Sharda Cropchem Ltd is a small-cap company in the Pesticides & Agrochemicals industry, reporting net sales of ₹2,065 Cr and a net profit of ₹319 Cr for the quarter ending March 2026. It was incorporated in 2004 and became a public company in 2013.

Overview:<BR>Sharda Cropchem Ltd is a company operating in the Pesticides & Agrochemicals industry, classified as a Small Cap entity.<BR><BR>History:<BR>Sharda Cropchem Limited was incorporated in 2004 as Sharda Worldwide Exports Private Limited and later changed its name to Sharda Cropchem Private Limited in 2013. It became a Public Limited Company on the same year. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 2,065 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 319 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 8,264 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 12.00<BR>- Industry P/E: 29<BR>- Dividend Yield: 1.36%<BR>- Debt Equity: -0.19<BR>- Return on Equity: 21.71%<BR>- Price to Book: 2.54<BR><BR>Contact Details:<BR>Address: Domnic Holm 29th Road, Bandra(West) Mumbai Maharashtra : 400050<BR>Tel: 91-22-66782800<BR>Email: co.sec@shardaintl.com<BR>Website: http://www.shardacropchem.com

Is Sharda Cropchem overvalued or undervalued?

As of November 21, 2025, Sharda Cropchem is considered fairly valued with a PE Ratio of 15.96 and strong growth potential, making it an attractive option in the pesticides sector, especially as it has outperformed the Sensex over the past three years.

As of 21 November 2025, Sharda Cropchem's valuation grade has moved from very attractive to attractive, indicating a shift in market perception. The company is currently considered fairly valued based on its financial metrics. Key ratios include a PE Ratio of 15.96, an EV to EBITDA of 8.40, and a PEG Ratio of 0.15, which suggests strong growth potential relative to its price.<BR><BR>In comparison to its peers, Sharda Cropchem's PE Ratio is significantly lower than UPL's 26.53 and P I Industries' 34.41, while its EV to EBITDA is also more favorable than UPL's 10.34. This positions Sharda Cropchem as an attractive option within the pesticides and agrochemicals sector. Notably, the company's stock has outperformed the Sensex over the past three years, returning 105.92% compared to the Sensex's 39.39%, reinforcing its growth story despite a recent dip in one-month performance.

Is Sharda Cropchem technically bullish or bearish?

As of 30 October 2025, Sharda Cropchem's trend is mildly bullish due to positive daily moving averages, despite mixed signals from weekly indicators suggesting caution.

As of 30 October 2025, the technical trend for Sharda Cropchem has changed from bullish to mildly bullish. The current stance is mildly bullish, driven primarily by the daily moving averages indicating a positive trend. However, the weekly MACD and KST are mildly bearish, suggesting some caution in the short term. The Bollinger Bands on the weekly timeframe are also bearish, contrasting with the monthly indicators that remain bullish. Overall, while there are mixed signals, the daily indicators support a mildly bullish outlook.

How has been the historical performance of Sharda Cropchem?

Sharda Cropchem has shown significant growth in net sales, rising from INR 2,003.02 crore in March 2020 to INR 4,319.85 crore in March 2025, with profit after tax increasing from INR 31.91 crore to INR 304.42 crore in the same period, reflecting strong operational performance and asset accumulation.

Answer:<BR>The historical performance of Sharda Cropchem shows significant growth in net sales and profitability over the years, with a notable increase in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Sharda Cropchem's net sales have risen from INR 2,003.02 crore in March 2020 to INR 4,319.85 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar pattern, reaching INR 4,319.85 crore in March 2025, up from INR 2,003.02 crore in March 2020. The company's total expenditure, excluding depreciation, also increased, amounting to INR 3,724.28 crore in March 2025. Operating profit (PBDIT) showed fluctuations, peaking at INR 683.38 crore in March 2023 before settling at INR 655.10 crore in March 2025. Profit before tax reached INR 378.34 crore in March 2025, a significant increase from INR 71.87 crore in March 2024. The profit after tax for March 2025 was INR 304.42 crore, compared to INR 31.91 crore in the previous year. The company's total assets grew to INR 4,713.29 crore in March 2025, up from INR 2,342.83 crore in March 2020, while total liabilities also increased to INR 4,713.29 crore. The cash flow from operating activities improved to INR 603.00 crore in March 2025, indicating a solid operational performance. Overall, Sharda Cropchem has demonstrated robust growth in sales, profits, and asset accumulation over the years.

Who are the top shareholders of the Sharda Cropchem?

The top shareholders of Sharda Cropchem include promoters, with Ashish Ramprakash Bubna holding 16.83%, mutual funds at 10.02% (led by HDFC Small Cap Fund at 7.26%), foreign institutional investors at 4.69%, and individual investors at 7.69%. There are no pledged promoter holdings.

The top shareholders of Sharda Cropchem include a mix of promoters, mutual funds, and individual investors. The majority shareholders are the promoters, with Ashish Ramprakash Bubna holding the largest stake at 16.83%. Mutual funds collectively hold 10.02% of the company, with the HDFC Small Cap Fund being the highest public shareholder at 7.26%. Additionally, foreign institutional investors (FIIs) own 4.69%, and individual investors hold 7.69%. Notably, there are no pledged promoter holdings.

Has Sharda Cropchem declared dividend?

Yes, Sharda Cropchem Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of February 6, 2025. The company has shown strong total returns over various periods, particularly a 334.45% total return over the past 5 years.

Sharda Cropchem Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3<BR>- Ex-date: 06 Feb 25<BR><BR>Dividend Yield: 0.76%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -5.86%, the dividend return was 0.36%, resulting in a total return of -5.5%.<BR><BR>Over the past year, there was a price return of 101.18%, a dividend return of 1.41%, leading to a total return of 102.59%.<BR><BR>In the 2-year period, the price return was 40.73%, the dividend return was 1.69%, which resulted in a total return of 42.42%.<BR><BR>For the 3-year period, the price return stood at 10.57%, with a dividend return of 2.54%, culminating in a total return of 13.11%.<BR><BR>In the last 4 years, the price return was 122.62%, the dividend return was 6.10%, resulting in a total return of 128.72%.<BR><BR>Over the past 5 years, the price return reached 325.71%, with a dividend return of 8.74%, leading to a total return of 334.45%.<BR><BR>Overall, Sharda Cropchem's dividend declaration reflects a commitment to returning value to shareholders, and the total returns over various periods indicate strong performance, particularly in the longer term.